<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31512106</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Cellular Caspase-3 Contributes to EV-A71 2A<sup>pro</sup>-Mediated Down-Regulation of IFNAR1 at the Translation Level.</ArticleTitle><Pagination><StartPage>64</StartPage><EndPage>72</EndPage><MedlinePgn>64-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12250-019-00151-y</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) is the major pathogen responsible for the severe hand, foot and mouth disease worldwide, for which few effective antiviral drugs are presently available. Interferon-&#x3b1; (IFN-&#x3b1;) has been used in antiviral therapy for decades; it has been reported that EV-A71 antagonizes the antiviral activity of IFN-&#x3b1; based on viral 2A<sup>pro</sup>-mediated reduction of the interferon-alpha receptor 1 (IFNAR1); however, the mechanism remains unknown. Here, we showed a significant increase in IFNAR1 protein induced by IFN-&#x3b1; in RD cells, whereas EV-A71 infection caused obvious down-regulation of the IFNAR1 protein and blockage of IFN-&#x3b1; signaling. Subsequently, we observed that EV-A71 2A<sup>pro</sup> inhibited IFNAR1 translation by cleavage of the eukaryotic initiation factor 4GI (eIF4GI), without affecting IFNAR1 mRNA levels induced by IFN-&#x3b1;. The inhibition of IFNAR1 translation also occurred in puromycin-induced apoptotic cells when caspase-3 cleaved eIF4GI. Importantly, we verified that 2A<sup>pro</sup> could activate cellular caspase-3, which was subsequently involved in eIF4GI cleavage mediated by 2A<sup>pro</sup>. Furthermore, inhibition of caspase-3 activation resulted in the partial restoration of IFNAR1 in cells transfected with 2A or infected with EV-A71, suggesting the pivotal role of both viral 2A<sup>pro</sup> and caspase-3 activation in the disturbance of IFN-&#x3b1; signaling. Collectively, we elucidate a novel mechanism by which cellular caspase-3 contributes to viral 2A<sup>pro</sup>-mediated down-regulation of IFNAR1 at the translation level during EV-A71 infection, indicating that caspase-3 inhibition could be a potential complementary strategy to improve clinical anti-EV-A71 therapy with IFN-&#x3b1;.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Bangtao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pei</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Sanyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yihong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-3603-8014</Identifier><AffiliationInfo><Affiliation>Department of Microbiology &amp; Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100083, China. ypeng78@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507964">IFNAR1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>156986-95-7</RegistryNumber><NameOfSubstance UI="D053633">Receptor, Interferon alpha-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C505407">CASP3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053148" MajorTopicYN="N">Caspase 3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="Y">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="Y">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053633" MajorTopicYN="N">Receptor, Interferon alpha-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012208" MajorTopicYN="N">Rhabdomyosarcoma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2A protease (2Apro)</Keyword><Keyword MajorTopicYN="N">Caspase-3</Keyword><Keyword MajorTopicYN="N">Enterovirus A71 (EV-A71)</Keyword><Keyword MajorTopicYN="N">Eukaryotic initiation factor 4GI (eIF4GI)</Keyword><Keyword MajorTopicYN="N">Interferon alpha receptor 1 (IFNAR1)</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31512106</ArticleId><ArticleId IdType="pmc">PMC7035401</ArticleId><ArticleId IdType="doi">10.1007/s12250-019-00151-y</ArticleId><ArticleId IdType="pii">10.1007/s12250-019-00151-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Araya RE, Goldszmid RS. IFNAR1 degradation: a new mechanism for tumor immune evasion? Cancer Cell. 2017;31:161&#x2013;163. doi: 10.1016/j.ccell.2017.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2017.01.012</ArticleId><ArticleId IdType="pmc">PMC7886182</ArticleId><ArticleId IdType="pubmed">28196588</ArticleId></ArticleIdList></Reference><Reference><Citation>Castell&#xf3; A, Alvarez E, Carrasco L. The multifaceted poliovirus 2A protease: regulation of gene expression by picornavirus proteases. J Biomed Biotechnol. 2011;2011:369648. doi: 10.1155/2011/369648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/369648</ArticleId><ArticleId IdType="pmc">PMC3085340</ArticleId><ArticleId IdType="pubmed">21541224</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YH, Lau KS, Kuo R, Horng JT. dsRNA binding domain of PKR is proteolytically released by enterovirus A71 to facilitate viral replication. Front Cell Infect Microbiol. 2017;7:284. doi: 10.3389/fcimb.2017.00284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00284</ArticleId><ArticleId IdType="pmc">PMC5487429</ArticleId><ArticleId IdType="pubmed">28702377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow KT, Gale M., Jr SnapShot: interferon signaling. Cell. 2015;163:1808. doi: 10.1016/j.cell.2015.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.008</ArticleId><ArticleId IdType="pubmed">26687364</ArticleId></ArticleIdList></Reference><Reference><Citation>Deszcz L, Seipelt J, Vassilieva E, Roetzer A, Kuechler E. Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase. FEBS Lett. 2004;560:51&#x2013;55. doi: 10.1016/S0014-5793(04)00069-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(04)00069-9</ArticleId><ArticleId IdType="pubmed">14987997</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan H, Zhu M, Xiong Q, Wang Y, Xu C, Sun J, Wang C, Zhang H, Xu P, Peng Y. Regulation of enterovirus 2A protease-associated viral IRES activities by the cell&#x2019;s ERK signaling cascade: implicating ERK as an efficiently antiviral target. Antiviral Res. 2017;143:13&#x2013;21. doi: 10.1016/j.antiviral.2017.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.03.018</ArticleId><ArticleId IdType="pubmed">28351508</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs SY. Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy. J Interferon Cytokine Res. 2013;33:211&#x2013;225. doi: 10.1089/jir.2012.0117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2012.0117</ArticleId><ArticleId IdType="pmc">PMC3624693</ArticleId><ArticleId IdType="pubmed">23570388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu YY, Liu YN, Lu WW, Kung SH. Visualizing and quantifying the differential cleavages of the eukaryotic translation initiation factors eIF4GI and eIF4GII in the enterovirus-infected cell. Biotechnol Bioeng. 2009;104:1142&#x2013;1152. doi: 10.1002/bit.22495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bit.22495</ArticleId><ArticleId IdType="pubmed">19655339</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341:936&#x2013;942. doi: 10.1056/NEJM199909233411302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Liao Q, Ooi MH, Cowling BJ, Chang Z, Wu P, Liu F, Li Y, Luo L, Yu S, Yu H, Wei S. Epidemiology of recurrent hand, foot and mouth disease, China, 2008&#x2013;2015. Emerg Infect Dis. 2018;24:432&#x2013;442. doi: 10.3201/eid2403.171303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2403.171303</ArticleId><ArticleId IdType="pmc">PMC5823341</ArticleId><ArticleId IdType="pubmed">29460747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Wang HC, Shih SR, Teng IF, Tseng CP, Hsu JT. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J Infect Dis. 2011;203:1784&#x2013;1790. doi: 10.1093/infdis/jir174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir174</ArticleId><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Zhang R, Wu W, Duan G. Innate immunity evasion by enteroviruses linked to epidemic hand&#x2013;foot&#x2013;mouth disease. Front Microbiol. 2018;9:2422. doi: 10.3389/fmicb.2018.02422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02422</ArticleId><ArticleId IdType="pmc">PMC6186807</ArticleId><ArticleId IdType="pubmed">30349526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kao LT, Lin SJ, Wang RY, Shih SR. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS ONE. 2013;8:e63431. doi: 10.1371/journal.pone.0063431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063431</ArticleId><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KM, Chen CJ, Shih SR. Regulation mechanisms of viral IRES-Driven translation. Trends Microbiol. 2017;25:546&#x2013;561. doi: 10.1016/j.tim.2017.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2017.01.010</ArticleId><ArticleId IdType="pubmed">28242053</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JY, Son M, Kang JH, Choi UY. Serum interleukin-6 levels as an indicator of aseptic meningitis among children with enterovirus 71-induced hand, foot and mouth disease. Postgrad Med. 2018;130:258&#x2013;263. doi: 10.1080/00325481.2018.1416257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00325481.2018.1416257</ArticleId><ArticleId IdType="pubmed">29231065</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chang Z, Wu P, Liao Q, Liu F, Zheng Y, Luo L, Zhou Y, Chen Q, Yu S, Guo C, Chen Z, Long L, Zhao S, Yang B, Yu H, Cowling BJ. Emerging enteroviruses causing hand, foot and mouth disease, China, 2010&#x2013;2016. Emerg Infect Dis. 2018;24:1902&#x2013;1906. doi: 10.3201/eid2410.171953.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2410.171953</ArticleId><ArticleId IdType="pmc">PMC6154135</ArticleId><ArticleId IdType="pubmed">30226172</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zhang Z, Zhao X, Yu R, Zhang X, Wu S, Liu J, Chi X, Song X, Fu L, Yu Y, Hou L, Chen W. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol. 2014;27:267&#x2013;276. doi: 10.1089/vim.2013.0127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2013.0127</ArticleId><ArticleId IdType="pubmed">24905060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol. 2012;86:3767&#x2013;3776. doi: 10.1128/JVI.06687-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Marissen WE, Lloyd RE. Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. Mol Cell Biol. 1998;18:7565&#x2013;7574. doi: 10.1128/MCB.18.12.7565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.18.12.7565</ArticleId><ArticleId IdType="pmc">PMC109337</ArticleId><ArticleId IdType="pubmed">9819442</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison JM, Racaniello VR. Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. J Virol. 2009;83:4412&#x2013;4422. doi: 10.1128/JVI.02177-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02177-08</ArticleId><ArticleId IdType="pmc">PMC2668472</ArticleId><ArticleId IdType="pubmed">19211759</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. Crystal structure of human enterovirus 71. Science. 2012;336:1274. doi: 10.1126/science.1218713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xe9;v&#xf4;t D, Darlix JL, Ohlmann T. Conducting the initiation of protein synthesis: the role of eIF4G. Biol Cell. 2003;95:141&#x2013;156. doi: 10.1016/S0248-4900(03)00031-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0248-4900(03)00031-5</ArticleId><ArticleId IdType="pubmed">12867079</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M, Khanbabaei H, Teimoori A. An update on enterovirus 71 infection and interferon type I response. Rev Med Virol. 2019;29:e2016. doi: 10.1002/rmv.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2016</ArticleId><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008;8:559&#x2013;568. doi: 10.1038/nri2314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2314</ArticleId><ArticleId IdType="pmc">PMC2522268</ArticleId><ArticleId IdType="pubmed">18575461</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F, Yu X, Zhong T, Wang Z, Meng X, Li Z, Zhang S, Huo W, Liu X, Zhang Y, Zhang W, Yu J. Caspase-3 inhibition attenuates the cytopathic effects of EV71 infection. Front Microbiol. 2018;9:817. doi: 10.3389/fmicb.2018.00817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00817</ArticleId><ArticleId IdType="pmc">PMC5932146</ArticleId><ArticleId IdType="pubmed">29755438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Zhou R, Zhang Z, Jin Y, Cardona CJ, Xing Z. Intrinsic apoptosis and proinflammatory cytokines regulated in human astrocytes infected with enterovirus 71. J Gen Virol. 2015;96:3010&#x2013;3022. doi: 10.1099/jgv.0.000235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000235</ArticleId><ArticleId IdType="pubmed">26296773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CY, Huang AC, Hour MJ, Huang SH, Kung SH, Chen CH, Chen IC, Chang YS, Lien JC, Lin CW. Antiviral potential of a novel compound CW-33 against enterovirus A71 via inhibition of viral 2A protease. Viruses. 2015;7:3155&#x2013;3171. doi: 10.3390/v7062764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7062764</ArticleId><ArticleId IdType="pmc">PMC4488731</ArticleId><ArticleId IdType="pubmed">26090728</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Li Yuhuan. Recent Progress on Functional Genomics Research of Enterovirus 71. Virol Sin. 2019;34:9&#x2013;21. doi: 10.1007/s12250-018-0071-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-018-0071-9</ArticleId><ArticleId IdType="pmc">PMC6420560</ArticleId><ArticleId IdType="pubmed">30552635</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Sun M, Yuan X, Ji L, Jin Y, Cardona CJ, Xing Z. Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-&#x3b1;1 degradation. J Biol Chem. 2017;292:10262&#x2013;10274. doi: 10.1074/jbc.M116.745729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.745729</ArticleId><ArticleId IdType="pmc">PMC5473229</ArticleId><ArticleId IdType="pubmed">28455446</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Cowling BJ. Remaining challenges for prevention and control of hand, foot, and mouth disease. Lancet Child Adolesc Health. 2019;19:373&#x2013;374. doi: 10.1016/S2352-4642(19)30065-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(19)30065-3</ArticleId><ArticleId IdType="pubmed">30885695</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J, Shen L, Wu J, Zou X, Gu J, Chen J, Mao L. Enterovirus A71 proteins: structure and function. Front Microbiol. 2018;9:286. doi: 10.3389/fmicb.2018.00286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00286</ArticleId><ArticleId IdType="pmc">PMC5826392</ArticleId><ArticleId IdType="pubmed">29515559</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamora M, Marissen WE, Lloyd RE. Multiple eIF4GI-specific protease activities present in uninfected and poliovirus-infected cells. J Virol. 2002;76:165&#x2013;177. doi: 10.1128/JVI.76.1.165-177.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.1.165-177.2002</ArticleId><ArticleId IdType="pmc">PMC135685</ArticleId><ArticleId IdType="pubmed">11739682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Feng H, Luo L, Zhou Q, Luo Z, Peng Y. Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2. Virus Res. 2010;150:22&#x2013;27. doi: 10.1016/j.virusres.2010.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2010.02.007</ArticleId><ArticleId IdType="pmc">PMC2860046</ArticleId><ArticleId IdType="pubmed">20172001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Li J, Li Q. Immune evasion of enteroviruses under innate immune monitoring. Front Microbiol. 2018;9:1866. doi: 10.3389/fmicb.2018.01866.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.01866</ArticleId><ArticleId IdType="pmc">PMC6102382</ArticleId><ArticleId IdType="pubmed">30154774</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M, Duan H, Gao M, Zhang H, Peng Y. Both ERK1 and ERK2 are required for enterovirus 71 (EV71) efficient replication. Viruses. 2015;7:1344&#x2013;1356. doi: 10.3390/v7031344.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7031344</ArticleId><ArticleId IdType="pmc">PMC4379574</ArticleId><ArticleId IdType="pubmed">25803100</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>